Stockhub

Medigen Vaccine Biologics Corporation: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 06:2306:23, 23 September 2022 95.149.241.133 talk 983 bytes +983 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical t..."
Retrieved from "https://stockhub.co/research/Medigen_Vaccine_Biologics_Corporation"